Duplicate Literature Records in PV: The Compliance Risk No One Talks About, Until Inspection
Most pharmacovigilance (PV) teams treat duplicate literature records as an operational nuisance. A few cases get merged, a few line listings get cleaned up, and the case backlog moves forward. The problem is that this view holds only until an...
